{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:23:22Z","timestamp":1765610602643,"version":"3.45.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kaposi sarcoma is a vascular neoplasm linked to human herpes virus 8 and presents in four main variants. The development of Kaposi sarcoma, particularly the iatrogenic form, in younger women with autoimmune conditions such as multiple sclerosis is exceedingly rare and presents unique diagnostic and therapeutic challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report the case of a 48-year-old Arab woman with an 18-year history of multiple sclerosis managed with corticosteroids, who developed cutaneous iatrogenic Kaposi sarcoma on her lower extremities. The diagnosis was delayed for 2 years as the lesions were initially misattributed to her underlying multiple sclerosis. A skin biopsy eventually confirmed Kaposi sarcoma, and staging revealed localized cutaneous disease with no visceral involvement. The patient was treated with weekly paclitaxel, showing a favorable response. Due to conflict-related logistical issues, treatment was temporarily switched to vincristine and vinorelbine, which resulted in disease progression and adverse effects. Paclitaxel was successfully reintroduced, leading to sustained clinical improvement, and 2 years after completing therapy, the patient remains in good health with no evidence of Kaposi sarcoma recurrence or multiple sclerosis exacerbation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case expands the known clinical and demographic spectrum of Kaposi sarcoma, underscoring the importance of maintaining a high index of suspicion in atypical patient populations to prevent diagnostic delays. The co-occurrence of multiple sclerosis and Kaposi sarcoma underscores the importance of recognizing iatrogenic Kaposi sarcoma in patients receiving immunosuppressive therapy and calls for further research into the complex intersection of autoimmune disorders and iatrogenic treatment-related immune dysregulation in oncogenesis. This report underscores the importance of individualized, persistent therapeutic strategies in managing Kaposi sarcoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-025-05683-4","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:39:20Z","timestamp":1763735960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Kaposi sarcoma in a female patient with multiple sclerosis: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3173-1942","authenticated-orcid":false,"given":"Ahmad","family":"Al-Bitar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Alkhaledi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malek","family":"Alhamedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"1","key":"5683_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0300060520982829","volume":"49","author":"SA Chen","year":"2021","unstructured":"Chen SA, Wang LT, Chen ZH, et\u00a0al. Extensive cutaneous iatrogenic Kaposi\u2019s sarcoma after bullous pemphigoid treatment with oral methylprednisolone: a rare Chinese case report. J Int Med Res. 2021;49(1):1\u20136.","journal-title":"J Int Med Res"},{"key":"5683_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-022-03637-8","volume":"16","author":"PJ Wu","year":"2022","unstructured":"Wu PJ, Sun CS, Kuo HT, et\u00a0al. Iatrogenic Kaposi sarcoma of the small bowel in Crohn\u2019s disease following short-term use of immunomodulators: a case report and review of the literature. J Med Case Rep. 2022;16: 424.","journal-title":"J Med Case Rep"},{"issue":"6","key":"5683_CR3","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1590\/abd1806-4841.20165772","volume":"91","author":"R Lazzarini","year":"2016","unstructured":"Lazzarini R, Lellis RF, Lopes ASA, Brasil F. Iatrogenic Kaposi\u2019s sarcoma caused by corticosteroids. An Bras Dermatol. 2016;91(6):867\u20139.","journal-title":"An Bras Dermatol"},{"key":"5683_CR4","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000678","volume":"8","author":"P Wetwittayakhlang","year":"2021","unstructured":"Wetwittayakhlang P, Golovics PA, Afif W, Bessissow T, Lakatos PL. Tofacitinib-associated iatrogenic Kaposi sarcoma in a patient with ulcerative colitis. ACG Case Rep J. 2021;8: e00678.","journal-title":"ACG Case Rep J"},{"key":"5683_CR5","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000929","volume":"10","author":"S Sandlow","year":"2023","unstructured":"Sandlow S, Rai P, Shum A, et\u00a0al. Ozanimod-associated iatrogenic Kaposi sarcoma in a patient with ulcerative colitis. ACG Case Rep J. 2023;10: e00929.","journal-title":"ACG Case Rep J"},{"key":"5683_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2016.03.001","author":"S Walker","year":"2016","unstructured":"Walker S, Brew B. Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis. J Clin Neurosci. 2016. https:\/\/doi.org\/10.1016\/j.jocn.2016.03.001.","journal-title":"J Clin Neurosci"},{"key":"5683_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001556","author":"T Tully","year":"2015","unstructured":"Tully T, Barkley A, Silber E. Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod. Neurology. 2015. https:\/\/doi.org\/10.1212\/WNL.0000000000001556.","journal-title":"Neurology"},{"key":"5683_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.25259\/IJDVL_688_2021","volume":"88","author":"H Daflaoui","year":"2022","unstructured":"Daflaoui H, Saddouk H, Quadi I, Zizi N, Dikhaye S. Iatrogenic Kaposi\u2019s sarcoma induced by rituximab and corticosteroid treatment for pemphigus vegetans in an HIV-negative patient. Indian J Dermatol Venereol Leprol. 2022;88:409\u201312.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"5683_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1684\/ejd.2017.3027","volume":"27","author":"R Binois","year":"2017","unstructured":"Binois R, Nadal M, Esteve E, et\u00a0al. Cutaneous Kaposi sarcoma during treatment with superpotent topical steroids and methotrexate for bullous pemphigoid: three cases. Eur J Dermatol. 2017;27(4):369\u201374.","journal-title":"Eur J Dermatol"},{"issue":"3","key":"5683_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/ajd.12650","volume":"58","author":"S Chap","year":"2017","unstructured":"Chap S, Vu M, Robinson AJ, Braue A, Varigos GA, Scardamaglia L. Treatment of cutaneous iatrogenic Kaposi sarcoma with topical timolol. Australas J Dermatol. 2017;58(3):242\u20133.","journal-title":"Australas J Dermatol"},{"issue":"4","key":"5683_CR11","first-page":"645","volume":"56","author":"K Jerdan","year":"2017","unstructured":"Jerdan K, Brownell J, Singh M, Braniecki M, Chan L. A case report of iatrogenic cutaneous Kaposi sarcoma due to rituximab therapy for thrombotic thrombocytopenic purpura. Acta Oncol. 2017;56(4):645\u20137.","journal-title":"Acta Oncol"},{"issue":"5","key":"5683_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4103\/ijd.IJD_217_18","volume":"64","author":"C Baykal","year":"2019","unstructured":"Baykal C, Atci T, Buyukbabani N, Kutlay A. The spectrum of underlying causes of iatrogenic Kaposi\u2019s sarcoma in a large series: a retrospective study. Indian J Dermatol. 2019;64(5):392\u20139.","journal-title":"Indian J Dermatol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05683-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05683-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05683-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:39:20Z","timestamp":1763735960000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05683-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5683"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05683-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was deemed waived by the Institutional Review Board\/Biomedical Research Committee of Damascus University, as per institutional policy, which exempts single case reports and case series from formal review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate:"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"597"}}